Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19897852rdf:typepubmed:Citationlld:pubmed
pubmed-article:19897852lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C0278678lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C0233820lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C1176020lld:lifeskim
pubmed-article:19897852lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:19897852pubmed:issue3lld:pubmed
pubmed-article:19897852pubmed:dateCreated2010-3-1lld:pubmed
pubmed-article:19897852pubmed:abstractTextThis study aims to assess the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (RCC).lld:pubmed
pubmed-article:19897852pubmed:languageenglld:pubmed
pubmed-article:19897852pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19897852pubmed:citationSubsetIMlld:pubmed
pubmed-article:19897852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19897852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19897852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19897852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19897852pubmed:statusMEDLINElld:pubmed
pubmed-article:19897852pubmed:monthMarlld:pubmed
pubmed-article:19897852pubmed:issn1465-3621lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:TakahashiMasa...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:AkazaHideyuki...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:AgataNaokiNlld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:MikiTsuneharu...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:NonomuraNorio...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:YuasaTakeshiTlld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:UemuraHirotsu...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:HasegawaYoshi...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:NaitoSeijiSlld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:NiwakawaMasas...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:FujimotoHiroy...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:TomitaYoshihi...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:ShinoharaNobu...lld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:MugiyaSoichiSlld:pubmed
pubmed-article:19897852pubmed:authorpubmed-author:HoukBrettBlld:pubmed
pubmed-article:19897852pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19897852pubmed:volume40lld:pubmed
pubmed-article:19897852pubmed:ownerNLMlld:pubmed
pubmed-article:19897852pubmed:authorsCompleteYlld:pubmed
pubmed-article:19897852pubmed:pagination194-202lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:meshHeadingpubmed-meshheading:19897852...lld:pubmed
pubmed-article:19897852pubmed:year2010lld:pubmed
pubmed-article:19897852pubmed:articleTitleA phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety.lld:pubmed
pubmed-article:19897852pubmed:affiliationDepartment of Urology, University of Tsukuba, Graduate School of Comprehensive Human Sciences, Tsukuba 305-8576, Japan.lld:pubmed
pubmed-article:19897852pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19897852pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19897852pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:19897852pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed